Leveraging Predictive Dosing to Reduce Clinical Trial Risk

Rich Christie, MD, PhD, Chief Development Officer, AiCure

As Chief Development Officer at AiCure, Rich oversees the commercial development, sales and marketing of AiCure’s offerings. Previously, Rich served as Global Head, Development Science and Innovation at Roche, and as Vice President, Business Development in the M&A group of Johnson & Johnson. He was also the CEO of Solaris Therapeutics, a start-up developing small molecule inhibitors of E3 ligases, out of Columbia University.

Prior to his time in pharma, Rich spent 3 years at McKinsey & Co., serving the pharmaceutical, biotechnology and services sectors as an Engagement Manager and a year at Caxton Health Holdings, a healthcare-dedicated investment firm. Rich received an SB from MIT and an MD/PhD from Harvard, where he patented and developed novel optical methods for the study of Alzheimer’s disease.

Dooti Roy, PhD, Principal Methodology Statistician, Boehringer Ingelheim

Dooti is a statistician and researcher who enjoys solving complex problems to make clinical trials efficient in dynamic, cross-functional environments.

Ken Getz MBA, Director & Professor at Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Ken Getz is the Director and a professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded research on pharmaceutical R&D management and execution; protocol design optimization; contract service provider and investigative site management; eClinical technology; data usage; and patient engagement.

He is the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press and writes a bi-monthly column nominated for a Neal Award in Applied Clinical Trials.

He holds a number of board appointments in the private and public sectors and serves on the editorial boards of Pharmaceutical Medicine and Therapeutic Innovation and Regulatory Science. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. Ken is the founder of CenterWatch, a leading publisher in the clinical trials industry, and one of several businesses that he has created and sold.

Marlen Rattiner, VP, Product Management, AiCure (Moderator)

Marlen is Vice President of Product Management at AiCure. He has over 20 years’ experience managing the launch and product direction for dozens of web and mobile applications. Prior to AiCure, Marlen spent over 10 years working in EdTech and obtained a Master’s Degree in Educational Technology from NYU. He uses his background in educational technology and cognitive science to inform AiCure’s work designing a best-in-class solution for improving patient outcomes while reducing patient burden.